RRML - Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- January 2021 -
 
Evaluation of Plasma AA/DHA+EP... 11
The Role of MiR-124 in Bladder... 10
Molecular diagnostic of Ureapl... 9
Difficult to treat Proteeae st... 8
Assessment on the influence of... 8
The positive rate of IgM and I... 8
Romanian Review of Laboratory ... 7
Assessment of circulating tumo... 6
LSM3, NDUFB3, and PTGS2 may be... 5
Antibacterial and antitumor ac... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 22(2)/2014 DOI:10.2478/rrlm-2014-0023
XML
TXT

Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

Adina Stoian, Anca Bacârea, Anca Moţăţăianu, Mircea Stoian, Florina Gliga, Vladimir Bacârea, Duicu Carmen, Claudia Bănescu


Abstract:

The aim of this work was to study for the first time in Romania Insertion/Deletion (I/D) polymorphism of the Vascular Endothelial Growth Factor (VEGF) gene in a group of patients with established type 2 diabetes mellitus (DM) and diabetic peripheral neuropathy (DPN) compared with a control group. This was a case-control study consisting of a group of 84 patients with type 2 DM and DPN, diagnosed by clinical neurological examination and electrophysiological nerve conduction studies and a control group of 90 healthy volunteers. For deoxyribonucleic acid (DNA) isolation, a DNA purification kit from Zymo Research was used. In vitro amplification of DNA sequences was achieved by polymerase chain reaction (PCR). Selective in vitro amplification of a DNA fragment of known sequence is based on the principle of extension of a primer (“primer and PCR amplicon”). DNA fragments were separated by gel electrophoresis. For proper viewing and interpreting of agarose gels Vilbert Lourmat system was used. D allele frequency of VEGF was significantly higher in patients with diabetic peripheral neuropathy (53.57%) compared with controls (25%), p=0.0001. There is a positive association between I/D polymorphism of VEGF gene and the presence of diabetic peripheral polyneuropathy. Our study suggests that D allele of VEGF gene is a risk factor for the occurrence of DPN.

Keywords: polyneuropathy, I/D polymorphism, VEGF gene, diabetes mellitus

Received: 17.6.2013
Accepted: 17.3.2014
Published: 25.5.2014

 
  PDF Download full text PDF
(338 KB)
     
 
How to cite
Stoian A, Bacârea A, Moţăţăianu A, Stoian M, Gliga F, Bacârea V, et al. Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy. Rev Romana Med Lab. 2014;22(2):165-72. DOI:10.2478/rrlm-2014-0023